EQT Life Sciences

EQT Life Sciences, as part of EQT Private Capital, focuses on investing in innovative companies within the life sciences sector. Their investment strategy aims to create value by actively supporting portfolio companies through their deep sector expertise, digitalization capabilities, and extensive network. They leverage the EQT Network of industrial advisors to provide strategic guidance and operational support to their portfolio companies. A key part of their approach involves digitalization, using data and technology to future-proof their investments and drive value creation across various industries affected by digital disruption. The firm also emphasizes a responsible and sustainable approach to investment, aligning with EQT's broader mission of creating value for society. Through partnerships and initiatives, they aim to support the wider community and contribute to a long-term positive impact. This involves integrating sustainability considerations into their investment process and promoting responsible ownership. EQT Life Sciences leverages the “EQT Motherbrain”, which is a proprietary AI platform used to source and assess companies, as well as improve the operational efficiency of their portfolio companies. EQT Life Sciences distinguishes itself through a comprehensive value creation approach, leveraging both internal expertise and a network of external advisors to drive growth and innovation in its portfolio companies. EQT Life Science is also known to collaborate with other funds focused on specific fields such as the LSP Dementia Fund.

Pharmaceuticals, Biotechnology, Medical Devices, Healthcare Services, Neurodegenerative Diseases, Rare Endocrine Disorders, Stroke Treatment

Core thematic spaces, technologies, and target market segments of interest.